CoChat

Myocardial Parvovirus B19 Persistence: Lack of Association With Clinicopathologic Phenotype in Adults With Heart Failure

Open access
Stewart, Garrick C., Lopez-Molina, Javier, Gottumukkala, Raju V.S.R.K., Rosner, Gregg F., Anello, Mary S., Hecht, Jonathan L., Winters, Gayle L., Padera, Robert F., Baughman, Kenneth L., Lipes, Myra A. · 2011 · Circulation: Heart Failure
Cited by 72

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background—: Multiple viruses have been isolated from the heart, but their significance remains controversial. We sought to determine the prevalence of cardiotropic viruses in endomyocardial biopsy (EMB) samples from adult patients with heart failure (HF) and to define the clinicopathologic profile of patients exhibiting viral positivity. Methods and Results—: EMB from 100 patients (median ejection fraction, 30%; interquartile range [IQR], 20% to 45%) presenting for cardiomyopathy evaluation (median symptom duration, 5 months; IQR, 1 to 13 months) were analyzed by polymerase chain reaction for adenovirus, cytomegalovirus, enteroviruses, Epstein-Barr virus, and parvovirus B19. Each isolate was sequenced, and viral load was determined. Parvovirus B19 was the only virus detected in EMB samples (12% of subjects). No patient had antiparvovirus IgM antibodies, but all had IgG antibodies, suggesting viral persistence. The clinical presentation of parvovirus-positive patients was markedly heterogeneous with both acute and chronic HF, variable ventricular function, and ischemic cardiomyopathy. No patient met Dallas histopathologic criteria for active or borderline myocarditis. Two patients with a positive cardiac MRI and presumed “parvomyocarditis” had similar viral loads to autopsy controls without heart disease. The oldest parvovirus-positive patients were positive for genotype 2, suggesting lifelong persistence in the myocardium. Conclusions—: Parvovirus B19 was the only virus isolated from EMB samples in this series of adult patients with HF from the United States. Positivity was associated with a wide array of clinical presentations and HF phenotypes. Our studies do not support a causative role for parvovirus B19 persistence in HF and, therefore, advocate against the use of antiviral therapy for these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.110.958249

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 72

Metadata

Authors
Stewart, G. C., Lopez-Molina, J., Gottumukkala, R. V. S. R. K., Rosner, G. F., Anello, M. S., Hecht, J. L., Winters, G. L., Padera, R. F., Baughman, K. L., & Lipes, M. A.
Venue
Circulation: Heart Failure
Published
2011-01
Volume
4
Issue
1
Pages
71-78
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2151448987
Cited by
72
References
2
FWCI
4.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myocardial Parvovirus B19 Persistence: Lack of Association With Clinicopathologic Phenotype in Adults With Heart Failure. https://app.cochat.ai/papers/10.1161/circheartfailure.110.958249
The paper
Stewart, G. C., Lopez-Molina, J., Gottumukkala, R. V. S. R. K., Rosner, G. F., Anello, M. S., Hecht, J. L., Winters, G. L., Padera, R. F., Baughman, K. L., & Lipes, M. A. (2011). Myocardial Parvovirus B19 Persistence: Lack of Association With Clinicopathologic Phenotype in Adults With Heart Failure. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.110.958249

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.